BioSpace News Archive

Business

Marrone Bio Innovations Signs Exclusive Distribution Agreement with Kenya Biologics for Kenya and Tanzania

The exclusive agreement includes Reysana (Regalia), Grandevo, Venerate and Majestene.

October 18, 2017
·
4 min read
Pharm Country

Conceivex Release: Nation’s Leading Fertility Therapy Company Appoints Life Sciences Veteran To Board of Directors

Conceivex, maker of The Conception Kit at-home system, today named veteran life sciences industry executive Michael S. Rosen to its Board of Directors.

October 18, 2017
·
3 min read
Interpace Diagnostics Presents New Data from Over 3,400 Patients Tested with ThyGenX/ThyraMIR

Conclusions will be presented at the American Thyroid Association annual meeting.

October 18, 2017
·
6 min read
Pharm Country

Celsion Provides Summary of Research and Development Day Held on October 12, 2017

Leading ovarian cancer and immunotherapy experts discuss GEN-1 clinical programs in newly diagnosed Stage III/IV ovarian cancer patients.

October 18, 2017
·
6 min read
Drug Development

Innovation Pharmaceuticals to Complete Phase II Trial of Brilacidin for Oral Mucositis in Cancer Patients

As announced on October 2, 2017, the last patient recently completed the therapeutic regimen in the double-blind study.

October 18, 2017
·
7 min read
Deals

Novan Acquires IP Rights to Treat Viral Malignancies With Nitric Oxide

Novan completed a transaction with KNOW Bio, LLC granting Novan exclusive worldwide rights for certain oncovirus applications of nitric oxide-based products.

October 18, 2017
·
8 min read
Business

Misonix to Report First Quarter Fiscal Year 2018 Financial Results on Tuesday, November 7, 2017

Conference call to be conducted same day at 4:30 pm ET.

October 18, 2017
·
2 min read
Mettler Toledo Release: November Conference Will Explore Revolutionary Fast Scanning Calorimetry Technique, With Optional Hands-On Training

METTLER TOLEDO is pleased to announce the dates of its 2017 conference exploring Flash DSC technology.

October 18, 2017
·
2 min read
Policy

FibroGen Announces Acceptance by China FDA of Roxadustat New Drug Application (NDA) for Treatment of Anemia Associated With Dialysis and Non-Dialysis Chronic Kidney Disease (CKD)

The NDA submission triggers a $15 million milestone payment, payable to FibroGen by AstraZeneca.

October 18, 2017
·
7 min read
Business

Edge Therapeutics Announces Third Quarter Financial Results Conference Call on November 1, 2017

The conference call will be available via phone and webcast.

October 18, 2017
·
2 min read